Forefront Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Forefront Wealth Partners's LLY Position: Q1 2026 in Review
Forefront Wealth Partners increased its Eli Lilly (LLY) stake by 5.5% in Q1 2026, buying an estimated $40.6K and bringing the position to 771 shares worth $709K. The position accounts for 0.3% of the portfolio, ranked #75.
Forefront Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $786K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Forefront Wealth Partners held 771 shares of Eli Lilly worth $709K as of Q1 2026.
- Forefront Wealth Partners bought 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
- Eli Lilly made up 0.3% of Forefront Wealth Partners's portfolio in Q1 2026, its #75 holding.
- Forefront Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Forefront Wealth Partners's Eli Lilly position peaked at $786K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Forefront Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.